Anthony Maida

Anthony Maida

Technik-/Wissenschafts-/F&E-Leiter bei ONCOTELIC THERAPEUTICS, INC.

Vermögen: 67 102 $ am 31.05.2026

61 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Anthony E.
Maida
founded BioConsul Drug Development Corp.
in 1977, where he worked as Chairman from 1977 to 2010.
Dr. Maida also currently works at Dendri Therapeutics, Inc., as Chairman from 2003, Oncotelic Therapeutics, Inc., as Director & Chief Medical Officer, Oncotelic, Inc., as Director, and various other companies.
Dr. Maida also formerly worked at Jenner Biotherapies, Inc., as President & Chief Executive Officer from 1992 to 1999, Cell Pathways, Inc., as President & Chief Executive Officer from 1980 to 1992, CancerVax Corp., as President & Chief Executive Officer from 2000 to 2001, and various other companies.
Dr. Maida received his undergraduate degree in 1977 from San Jose State University, graduate degree in 1986 from San Jose State University, Masters Business Admin degree in 1978 from Santa Clara University, undergraduate degree in 1975 from Santa Clara University, and doctorate degree in 2010 from the University of California.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
12.04.2025 1.137.314 ( 0,26 % ) 67 102 $ 31.05.2026

Aktive Positionen von Anthony Maida

UnternehmenPositionBeginn
ONCOTELIC THERAPEUTICS, INC. Technik-/Wissenschafts-/F&E-Leiter 11.05.2020
Direktor/Vorstandsmitglied -
Corporate Officer/Principal -
Dendri Therapeutics, Inc.
Vorsitzender 01.03.2003
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Anthony Maida

UnternehmenPositionEnde
░ ░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Anthony Maida im Detail an

Ausbildung von Anthony Maida

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

70

Beziehungen ersten Grades

32

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen32

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Distribution Services

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Services

Commercial Services

Dendri Therapeutics, Inc.

BioConsul Drug Development Corp.

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Replicon NeuroTherapeutics, Inc.

Data Plan, Inc.

Glycometrix, Inc.

Electronic Technology

Anthony Maida Consulting International

Consumer Services

Health Technology

Health Technology

Miscellaneous

Commercial Services

  1. Börse
  2. Insiders
  3. Anthony Maida
LETZTE CHANCE | -40 %: Die besten Tools exklusiv für Abonnenten - Ihr Schlüssel zu den Top-Investitionen der Zukunft!
T
:
:
PROFITIEREN SIE JETZT